You are here

Preeklamptik Gebe Kadınlarda ve Bebeklerinin Kordon Kanında, Nitrik Oksit Metabolitleri Olan Nitrit Ve Nitratın Plazma Düzeylerinin Araştırılması

Investigation Of Plasma Nitric Oxide Metabolites, Nitrite And Nitrate Levels In Preclamptic Pregnant Women And Cord Blood Of The Babies

Journal Name:

Publication Year:

Keywords (Original Language):

Abstract (2. Language): 
Nitric oxide (NO) is a vasodilator agent derived from vascular endothelium. It has been thought that decreased production of nitric oxide plays an important role in the pathogenesis of preclampsia. In this study, plasma nitric oxide metabolites, nitrate and nitrite levels were investigated among preclamptic pregnants and their newborn infants, and compared with control groups. Plasma samples were collected from 14 preclamptic pregnant women and 14 control pregnants besides cord blood of the newborn infants in both groups. Kinetic cadmium method was used as assay method for NO metabolites. In results, only in preclamptic pregnants, nitrate levels (49.01 + 8.65 umol/L, mean±SD) were significantly higher than control (41.86+8.57 umol/L)(p<0.05). There was no statistically significant difference between control and other groups with respect to nitrite and nitrate levels. These results show that the decreased endothelial nitric oxide production does not play an important role on physiopathology of preclampsia. On contrary high nitrate levels of preclamptic pregnants show the existence of increased nitric oxide production from an unknown source and the existence of a decreased urinary excretion.
Abstract (Original Language): 
Nitrik oksit damarlarda duvar tonusu üstünde belirgin gevşetici etkisi olan damar duvar endoteli kaynaklı bir vazodilatatördür. Preeklamptik gebelerde, disfonksiyonel endotel hücrelerinde, düşük düzeyde nitrik oksit üretiminin fizyopatolojide rolü olduğu düşünülmektedir. Bu çalışmada preeklamptik gebelerde ve bebeklerinde plazma nitrik oksit metabolitleri olan nitrik ve nitrat düzeyleri ölçülerek nitrik oksit üretimi konusunda fikir sahibi olunması amaçlandı. Bu amaçla hasta grubu olarak 14 preeklamptik gebe (PG) (n=14), kontrol grubu olarak 14 normal gebe kadın (KG) ve kord kanında çalışmak üzere preeklamptik gebelerin bebekleri (PB) (n=14) ve normal gebelerin bebekleri (KB) (n=14) seçildi. Nitrit ve nitrat tayin metodu olarak Griess (kinetik kadmiyum redüksiyonu) yöntemi kullanıldı. Bulgularda, PG nitrat düzeyleri (49.01 + 8.65 —mol/L; ortalama±SD ), KG nitrat düzeylerine göre anlamlı derecede yüksek bulundu (41.86+8.57 —mol/L)(p<0.05). Diğer parametrelerde kontrole göre anlamlı bir fark tesbit edilmedi. Bu sonuçlar azalmış endoteliyal hücre nitrik oksit üretiminin, preeklampsi fizyopatolojisinde etken olduğu hipotezini desteklememektedir. Tersine PG'lerdeki yüksek nitrat düzeyleri, bilinmeyen bir kaynaktan artmış nitrik oksit üretimini ya da idrar yolu ile itrah edilmesinde belirgin bir azalmayı düşündürmektedir.
1-4

REFERENCES

References: 

1. Moncada S, Palmer RMJ, Higgs EA. Nitric Oxide. Physsiology, pathophysiology and pharmacology. Pharmacol Reviews 1991; 43:109 -37
2. Lancaster J. Nitric Oxide, principles and actions. Copyright by Acedemic Press Inc. 1996 California - USA
3. Cortas NK., Wakid NB. De termination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin. Chem. 1990; 36: 1440 -3
4. Seligman SP, Buyon JP, Clancy RM, Young BK, Abramson SB. The role of nitric oxide in the pathogenesis of preeclampsia . Am J Obstet Gyne col. 1994; 171: 944¬8
5. Lyall F, Young A Greer Ia. Nitric oxide concentrations are increased in the feto placental circulation in preeclampsia. Am J Obstet Gynecol. 1995; 173:714 -8
6. Silver RK, kupferminc MJ, Russel TL, Adler L, Mullen TA, Caplan Ms. Evaluatio n of nitric oxide as a mediator of severe preeclampsia. Am J Obstet Gynecol. 1996;
175: 1013-7
7. Davidge ST, Stranko CP, Roberts JM. Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia. Am J Obstet Gynecol.
1996; 174: 1008-13
8. Begum S, Yamasaki M, Mochizuki M. The role of nitric oxide metabolites during pregnancy. Kobe J Med Sci. 1996; 42: 131 -41
9. Smarason AK, Allman KG, Young D, Redman CW. Elevated levels of s erum nitrate, a stable end product of nitric oxide, in women with p re-eclampsia. Br J
Obstet Gynaecol 1997; 104: 538-43
10. Di lorio R, Marinoni E, Emiliani S, Villacio B, Cosmi EV. Nitric oxide in preeclampsia: lack of evidence for decreased production. Eur J Obstet Reprod Biol. 1998; 76: 65-70
11. Norris LA, Higgins JR, Darling MR, Walshe JJ, Bonnar J. Nitric oxide in the uteroplacental, and peripheral circulations in preeclampsia. Obstet Gynecol. 1999;
93: 958-63
Karabulut ve ark
12. Mutlu -Turkoğlu U, Aykac-Toker G, Ibrahimoğlu L, Ademoğlu E, Uysal M.Plasma nitric oxide metabolites and lipid peroxide levels in preeclamptic pregnant women before and after delivery. Gynecol Obstet Invest. 1999; 48 :247-50
13. Paathak N, Sawhney H, Vasishta K, Majumdar S. Estimation of oxidative products of nitric oxide (nitrates,nitrites) in preeclampsia. Aust N Z J Obstet
Gynecol. 1999; 39: 484-7
14. Bartha JL, Comino-Delgado R, Bedoya FJ, Barahona M, Lubian D, Gacia-Benasach F. Maternal serum nitric oxide levels associated with biochemical and clinical parameters in hypertension in pregnancy. Eur J Obstet Reprod Biol. 1999;
82: 201-7
15. Conrad KP, Kerchner LJ, Mosher MD.Plasma and 24-h NO(x) and cGMP during normal pregnancy and preeclampsia in women on a reduced NO(x) diet. Am J
Physiol.1999; 277:F48-5

Thank you for copying data from http://www.arastirmax.com